GILD | Gilead Sciences Inc
Category: Biotechnology company
Quick infos Headquarters: Foster City, California, United States Trade prices Volume: 2.0M Market Cap: 78.22B Prev closed: 59.05 Open: 58.44 High: 61.45 Low: 58.18 52 week low: 57.04 52 week high: 85.97 Dividends: Next ER: February 2, 2023 After Market Closes
About the Company Gilead Sciences is an American biopharmaceutical company that discovers, develops and commercializes drugs.
Earnings History Date EPS / Forecast Revenue / Forecast February 7, 2023 - / 1.39- / 6.34BOctober 27, 2022 1.9 / 1.527B / 6.13BBeat! August 2, 2022 1.58 / 1.526.26B / 5.86BBeat! April 28, 2022 2.12 / 1.86.59B / 6.29BBeat! February 1, 2022 0.69 / 1.597.24B / 6.61BBeat! view more
Historical Data Date Price Open High Low Vol Change ER Aug 17, 2022 66.02 65.97 66.89
65.82
6.44M -0.47% Aug 16, 2022 66.33 66.16 66.42
65.65
7.06M 0.18% Aug 15, 2022 66.21 63.85 66.30
63.66
12.38M 5.16% Aug 12, 2022 62.96 62.71 62.99
62.15
4.00M 0.82% Aug 11, 2022 62.45 62.78 63.41
62.37
5.20M -1.09% Aug 10, 2022 63.14 62.49 63.19
62.11
8.25M 1.84% Aug 9, 2022 62.00 61.58 62.05
61.38
5.15M 0.65% Aug 8, 2022 61.60 61.00 61.71
60.81
5.86M 0.83% Aug 5, 2022 61.09 61.79 61.84
60.62
6.04M -1.32% Aug 4, 2022 61.91 62.14 62.99
61.83
5.51M -0.58% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company ISIN: US3755581036 CUSIP: 375558103 Founded:June 1987 Employees:9,000 News
Gilead's Kite unit to acquire CAR T therapy developer Tmunity Therapeutics seekingalpha.com Dec 20, 2022 10:05 pm
Billionaire Cliff Asness Top 10 Dividend Stocks finance.yahoo.com Dec 20, 2022 2:52 pm
Gilead (GILD) Outperforms YTD: Will It Retain the Momentum? finance.yahoo.com Dec 20, 2022 1:45 pm
Allogene (ALLO) Reports Narrower-Than-Expected Loss in Q3 finance.yahoo.com Dec 20, 2022 1:16 pm
Karuna Therapeutics (KRTX) Posts Wider-Than-Expected Q3 Loss finance.yahoo.com Dec 20, 2022 12:15 pm
Goldman Sachs Cheap Dividend Stocks finance.yahoo.com Dec 20, 2022 12:01 pm
Gilead-Arcus Biosciences Partnered Lung Cancer Therapy Shows Continuous Positive Efficacy Measures finance.yahoo.com Dec 20, 2022 11:18 am
Why Shares of Gilead Sciences Rose 27.20% in October fool.com Dec 20, 2022 11:00 am
Beat the Dow Jones With This Unstoppable Dividend Stock finance.yahoo.com Dec 20, 2022 10:53 am
Gilead unit to buy Carl June-founded Penn cell therapy spinout finance.yahoo.com Dec 20, 2022 10:27 am
New Analyses of Kite's Tecartus® CAR T-Cell Therapy Provide Additional Evidence Supporting Overall Survival and Durability of Response finance.yahoo.com Dec 20, 2022 10:00 am
Gilead-Arcus Partnered Domvanalimab Combo Study Show Improved Progression-Free Survival In Lung Cancer Patients finance.yahoo.com Dec 20, 2022 9:56 am
Gilead Sciences: All Stars Project Empowers Youth Through Performance finance.yahoo.com Dec 20, 2022 9:35 am
Has This Hot Stock Run Out of Steam? fool.com Dec 20, 2022 9:30 am
Is There An Opportunity With Gilead Sciences, Inc.'s (NASDAQ:GILD) 44% Undervaluation? finance.yahoo.com Dec 20, 2022 9:02 am
Is There An Opportunity With Gilead Sciences, Inc.'s (NASDAQ:GILD) 44% Undervaluation? finance.yahoo.com Dec 20, 2022 9:00 am
Gilead Sciences: Staying Positive While Facing Metastatic Triple-Negative Breast Cancer: Jacquie's Story finance.yahoo.com Dec 20, 2022 9:00 am
Investors in Gilead Sciences (NASDAQ:GILD) have made a notable return of 46% over the past three years finance.yahoo.com Dec 20, 2022 9:00 am
Gilead's Path to Equitable Global COVID-19 Treatment Access finance.yahoo.com Dec 20, 2022 8:55 am Arcus Biosciences, Gilead shares are down after sharing data about new lung cancer drug finance.yahoo.com Dec 20, 2022 8:47 am GILD Dividends Ex-Dividend Amount Announced Date Record Date Payment Date Dec 14, 2022 0.73 Dec 29, 2022 Sep 14, 2022 0.73 Sep 29, 2022 Jun 14, 2022 0.73 Jun 29, 2022 Mar 14, 2022 0.73 Mar 30, 2022 Dec 14, 2021 0.71 Dec 30, 2021 view more
Key Persons CEO : John F. Milligan, PhD Talk about Gilead Sciences Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Homepage: gilead.com Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.
